|
SCAND1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.58850000001143E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.42780000000897E-06 |
| Normal-vs-Stage2 |
4.963200E-01 |
| Normal-vs-Stage3 |
2.731800E-02 |
| Normal-vs-Stage4 |
6.603400E-01 |
| Stage1-vs-Stage2 |
1.922350E-02 |
| Stage1-vs-Stage3 |
1.419990E-01 |
| Stage1-vs-Stage4 |
5.568100E-02 |
| Stage2-vs-Stage3 |
2.925600E-01 |
| Stage2-vs-Stage4 |
4.631800E-01 |
| Stage3-vs-Stage4 |
9.614400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.7955000000205E-07 |
| Normal-vs-AfricanAmerican |
2.521800E-02 |
| Normal-vs-Asian |
6.853600E-01 |
| Caucasian-vs-AfricanAmerican |
6.586600E-01 |
| Caucasian-vs-Asian |
2.992400E-01 |
| AfricanAmerican-vs-Asian |
5.367000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.01219999995672E-06 |
| Normal-vs-Female |
1.357680E-02 |
| Male-vs-Female |
7.478600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.355790E-02 |
| Normal-vs-Extreme_Weight |
9.34210000025359E-07 |
| Normal-vs-Obese |
7.080300E-03 |
| Normal-vs-Extreme_Obese |
2.457600E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.351000E-01 |
| Normal_Weight-vs-Obese |
9.914600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.620000E-01 |
| Extreme_Weight-vs-Obese |
2.097800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.376000E-01 |
| Obese-vs-Extreme_Obese |
5.865000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.090400E-02 |
| Normal-vs-Age(41-60Yrs) |
4.613300E-04 |
| Normal-vs-Age(61-80Yrs) |
3.15559999997106E-06 |
| Normal-vs-Age(81-100Yrs) |
4.826200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.728200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.527000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.207900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.774800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.611200E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.74089999999527E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.21289997437424E-09 |
| Normal-VS-Type2 PRCC |
7.107400E-01 |
| Normal-VS-KIRP CIMP |
2.432400E-01 |
| Normal-VS-Unclassified PRCC |
1.717800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.5387999974823E-08 |
| Type1 PRCC-VS-KIRP CIMP |
3.231700E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
2.228600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.152200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.161600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.836000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.976100E-04 |
| Normal-vs-N1 |
3.045600E-01 |
| Normal-vs-N2 |
4.182000E-01 |
| N0-vs-N1 |
1.353450E-01 |
| N0-vs-N2 |
1.552770E-01 |
| N1-vs-N2 |
3.969800E-01 |
|
|
